Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.6450
+0.0500 (8.40%)
May 6, 2026, 9:40 AM EST
Orgenesis Employees
Orgenesis had 77 employees as of December 31, 2024. The number of employees decreased by 69 or -47.26% compared to the previous year.
Employees
77
Change (1Y)
-69
Growth (1Y)
-47.26%
Revenue / Employee
$13,442
Profits / Employee
-$625,519
Market Cap
5.83M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 77 | -69 | -47.26% | 77 | 0 |
| Dec 31, 2023 | 146 | -21 | -12.57% | 146 | 0 |
| Dec 31, 2022 | 167 | 16 | 10.60% | 167 | 0 |
| Dec 31, 2021 | 151 | 40 | 36.04% | 151 | 0 |
| Dec 31, 2020 | 111 | -198 | -64.08% | 111 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CASI Pharmaceuticals | 233 |
| Vaccinex | 27 |
| Mosaic ImmunoEngineering | 7 |
| AccuStem Sciences | 4 |
| Bioxytran | 2 |
Orgenesis News
- 5 weeks ago - Okogen Acquires Ranpirnase Assets and Intellectual Property Portfolio - Newsfile Corp
- 1 year ago - Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies - Accesswire
- 1 year ago - Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings - Accesswire
- 1 year ago - Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia - GlobeNewsWire
- 1 year ago - Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally - GlobeNewsWire
- 2 years ago - Orgenesis Provides Business Update for the First Quarter of 2024 - GlobeNewsWire
- 2 years ago - Orgenesis Provides Year End Business Update - GlobeNewsWire
- 2 years ago - Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility - GlobeNewsWire